Digital Therapeutics, DTx
Software-based Medical Device for Musculoskeletal Rehabilitation
*Digital therapeutics deliver to patients evidence-based therapeutic interventions that are driven by high quality software programs to treat, manage, or prevent a disease or disorder. They are used independently or in concert with medications, devices, or other therapies to optimize patient care and health outcomes.
- Digital Therapeutics Alliance
Sarcopenia is caused by
various factors such as aging.
It would inflict degeneration of skeletal muscle itself and its quality and power.
Reality of Sarcopenia
Sarcopenia,
newly classified as a disease
Sarcopenia has become a worldwide public health issue due to irreversible growth of global-scale aging population.
In reaction to the prevailing issue, World Health Organization and US classified sarcopenia as a diesase followed by Japan and Korea in 2018 and 2021.
10% of total population worldwide suffer from sarcopenia in which 5~13% is composed of 60s to 70s while 11~50% is composed of 80s and above.
Source 1): Shafiee, G., Keshtkar, A., Soltani, A. et al. (2017)
Source 2): Cuiying Wang; Li Bai, et al. (2012)
World Population suffering from Sarcopenia
10%
World Health Organization
International Classification of Disease Code
(ICD-10-CM) Listed: M62.84
2016
Republic of Korea
Classification of Disease Code Listed: M62.5
2021
U.S.
Classification of Disease Code Listed: M62.84
2016
Japan
Classification of Disease Code Listed
2018
Risk of Sarcopenia
Absence of practical method to diagnose and treat sarcopenia
"There is no specific guideline to diagnose or treat sarcopeania.
The need for better diagnostics, prevention, and self-care is cointinously growing"
U.S. 2016 Classification of Disease Code Listed: M62.84
- Sarcopenia is currently being diagnosed in a qualitative assessment without proper quantitative means.
- As a substitute for the cure for sarcopenia, protein beverage market is expanding. (The Global Protein Ingredients Market Size was valued at USD 52 Billion in 2021 and is predicted to be worth USD 103 Billion by 2030, with a CAGR of 8.1% from 2022 to 2030.)
Source 3): Papadopoulou, SK, et al. (2020)
Social Cost caused by Sarcopenia
"In order to mitigate the burden of social medical cost and improve the quality of aged lives, it is essential to equip individual sarcopenia monitoring and optimized management system."
Source 4): Gomez Cabrera M, Viña J. et al. (2020)
Our Solution
DTx,
Software-based medical device for musculoskeletal disorder treatment
Long term cardiovascular exercise lessens the lowering
muscle power due to aging.
Furthermore, weight training involving protein comsumption effectively diminishes the muscle functionality degeneration.
*Digital therapeutics deliver to patients evidence-based therapeutic interventions that are driven by high quality software programs to treat, manage, or prevent a disease or disorder. They are used independently or in concert with medications, devices, or other therapies to optimize patient care and health outcomes. - Digital Therapeutics Alliance
Digital Therapeutics, DTx